German regulator hails EMA's drugs suspension on GVK Bio data
German drug regulator has welcomed the European Medicine Agency's (EMA) decision to suspend the marketing authorisation of around 700 generic drugs subjected to clinical trials by India's GVK Biosciences.
Jan 24, 2015, 13:34 PM IST